Literature DB >> 7537589

An investigation into the mechanism of capsaicin-induced oedema in rabbit skin.

P Newbold1, S D Brain.   

Abstract

1. Oedema formation induced by intradermal capsaicin has been studied in rabbit skin. The effect of the anti-inflammatory steroid dexamethasone and also of a range of known inhibitors of oedema formation have been investigated in order to elucidate mechanisms involved in capsaicin-induced oedema formation. 2. Oedema formation, in response to intradermally-injected test agents, was measured by the local extravascular accumulation of intravenously injected 125I-labelled albumin. In separate experiments skin blood flow was assessed by the clearance of intradermally-injected 133xenon. 3. Oedema formation induced by intradermal histamine (3 nmol) and bradykinin (1 nmol), when in the presence of vasodilator doses of calcitonin gene-related peptide (CGRP) (3 pmol) or prostaglandin E1, (PGE1) (10 pmol), was significantly inhibited (P < 0.01) in rabbits pretreated with intravenous dexamethasone (3 mg kg-1, -4 h). In contrast dexamethasone had no effect on capsaicin (3 mumol)-induced oedema formation or, on capsaicin (30-100 nmol)-induced blood flow. 4. Oedema formation observed in response to intradermal capsaicin (3 mumol) was significantly inhibited (P < 0.01) when the selective capsaicin antagonist, ruthenium red (3 nmol) was co-injected. This suggests that the mechanism of capsaicin-induced oedema involves activation of sensory nerves. However, oedema was not inhibited when capsaicin was co-injected with the neurokinin NK1 receptor antagonist, RP67580 (10 nmol), the NK2 antagonist SR48960 (10 nmol) or the CGRP antagonist CGRP8-37 (300 pmol). 5. Oedema formation induced by capsaicin was not inhibited when co-injected with the histamine HI receptor antagonist, mepyramine (3 nmol), the PAF antagonist, WEB 2086 (100 nmol), the bradykinin B2 receptor antagonist, Hoel4O (1 nmol), or the cyclo-oxygenase inhibitor, indomethacin (10 nmol),suggesting that these mediators do not play a major role in the capsaicin-induced response.6. Histological analysis of capsaicin-treated skin sites revealed undamaged, intact microvessels and lack of haemorrhage. Further, co-injection of capsaicin with the hydrogen peroxide remover, catalase(2,200 u), had no effect on oedema formation. This suggests that capsaicin does not induce oedema formation secondary to free radical-induced damage.7. These results indicate that capsaicin-induced oedema in rabbit skin involves activation of sensory nerves. However, the oedema is not inhibited by pretreatment with the anti-inflammatory steroid,dexamethasone. Further the mechanisms which lead to the oedema formation observed after intradermal capsaicin remain unknown.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537589      PMCID: PMC1510027          DOI: 10.1111/j.1476-5381.1995.tb17177.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Methylprednisolone acts at the endothelial cell level reducing inflammatory responses.

Authors:  J Björk; T Goldschmidt; G Smedegård; K E Arfors
Journal:  Acta Physiol Scand       Date:  1985-02

2.  Prostaglandins as potentiators of increased vascular permeability in inflammation.

Authors:  T J Williams; J Morley
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

3.  Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin.

Authors:  J M Lundberg; A Franco-Cereceda; X Hua; T Hökfelt; J A Fischer
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

4.  Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.

Authors:  P Picard; S Boucher; D Regoli; B D Gitter; J J Howbert; R Couture
Journal:  Eur J Pharmacol       Date:  1993-03-02       Impact factor: 4.432

5.  Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

6.  The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro.

Authors:  S J Marsh; C E Stansfeld; D A Brown; R Davey; D McCarthy
Journal:  Neuroscience       Date:  1987-10       Impact factor: 3.590

7.  Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.

Authors:  S D Brain; T J Williams
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

8.  Substance P regulates the vasodilator activity of calcitonin gene-related peptide.

Authors:  S D Brain; T J Williams
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

9.  Calcitonin gene-related peptide and the lung: neuronal coexistence with substance P, release by capsaicin and vasodilatory effect.

Authors:  C R Martling; A Saria; J A Fischer; T Hökfelt; J M Lundberg
Journal:  Regul Pept       Date:  1988-02

10.  Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids.

Authors:  G J Blackwell; R Carnuccio; M Di Rosa; R J Flower; L Parente; P Persico
Journal:  Nature       Date:  1980-09-11       Impact factor: 49.962

View more
  7 in total

1.  THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 2.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 3.  The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Authors:  Nick Pantaleo; Wayne Chadwick; Sung-Soo Park; Liyun Wang; Yu Zhou; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

4.  Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging.

Authors:  B J Van der Schueren; J N de Hoon; F H Vanmolkot; A Van Hecken; M Depre; S A Kane; I De Lepeleire; S R Sinclair
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

5.  A Tuneable, Photocurable, Poly(Caprolactone)-Based Resin for Tissue Engineering-Synthesis, Characterisation and Use in Stereolithography.

Authors:  Jonathan Field; John W Haycock; Fiona M Boissonade; Frederik Claeyssens
Journal:  Molecules       Date:  2021-02-24       Impact factor: 4.927

6.  Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.

Authors:  Leonardo Lorente; María M Martín; Teresa Almeida; Mariano Hernández; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; Alejandro Jiménez
Journal:  Crit Care       Date:  2015-04-27       Impact factor: 9.097

7.  Neurogenic mediators contribute to local edema induced by Micrurus lemniscatus venom.

Authors:  Luciana Lyra Casais-E-Silva; Catarina Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2017-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.